Corvus pharmaceuticals inc.

Major-Pharmaceuticals

CRVS


863 Mitten Road
Burlingame , CA 94010

Executive/
Director

Price

  • Last Close
  • $ 4.17
    $ +0.07 1.71 %
    Aug 29, 2024
  • 52-Week High/Low
  • $4.3 - $1.08
  • YTD
  • 136.9%

  • Trading Volume
  • 5,075
  • Market Cap Full
  • $ 204.5M
  • Shares Outstanding
  • 49M
    Nov 7, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - 45.2% 11.3% 9.5% -5% -13.5% -31.5% 7.1% 1.1%
Q2 - -1.7% -41.7% 1.1% -18% 4% -13.3% -40% 151.7% -
Q3 - 15.4% 31.7% -19% -17.5% 8% 81.3% -17.3% -36.2% -
Q4 - -13.1% -38.8% -55.4% 64.8% -11.2% -50.2% 3.8% 24.8% -
J F M A M J J A S O N D
2024 13.6% 12% -20.5% 4.5% - - - - - - - -
2023 -3.5% -11% 24.7% 18.7% 181.5% -24.7% -1.8% -5.8% -31.1% -22.6% 35.4% 15%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%-28%-65%41%-31%-32%-65%107%137%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - 5.39 0.79 -0.63 -0.4 -0.44 -0.34 -0.18 -0.17
Q2 - 0.43 0.73 -0.4 -0.44 -0.36 -0.28 -0.18 -0.14
Q3 - 0.51 0.62 -0.36 -0.37 -0.33 -0.24 -0.32 -0.12
Q4 - 0.55 0.58 -0.32 -0.38 0.93 -0.17 -0.21 -
A 0 6.9 2.7 -1.7 -1.6 -0.2 -1 -0.9 -0.43

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 29.3 29.3 38.3 46.6 46.6
Jun 29.2 29.3 28 38.3 46.6 46.6
Sep 29.2 29.4 28 42.4 46.6 49
Dec 29.3 29.4 28.1 46.5 46.6 49

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage -4.1 -9.8 1.2 24.5 24.5
Equity multiplier 0.4 0.4 0.5 - -